Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 16 November 2026
- Last conf. stmt
- 2 November 2025
Iksuda Therapeutics Limited
- Incorporated
- 21 November 2007 (18 years)
- Previously known as
- Glythera Limited (until 7 September 2018)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Yong Zu KimSe Jin ParkJose Ponte
- Accounts type
- Full
- Region
- North East
- Address
- The Biosphere Draymans WayNewcastle HelixNewcastle Upon TyneNE4 5BX
Officers 5 active
Officer details are public data from the Companies House register.
Kim, Yong Zu
Director · Appointed 14 March 2025
South Korean
Born May 1956 (70)
Park, Se Jin
Director · Appointed 14 March 2025
South Korean
Born March 1962 (64)
Ponte, Jose, Dr
Director · Appointed 28 October 2024
American
Born March 1971 (55)
Director · Appointed 28 March 2014
British
Born December 1972 (53)
Corporate Director · Appointed 4 September 2008
Officer history (19 former)
14 March 2025
Resigned Chae, Jeiwook as Director
14 March 2025
Appointed Park, Se Jin as Director
14 March 2025
Appointed Kim, Yong Zu as Director
14 March 2025
Resigned Jang, Seungdeok as Director
28 October 2024
Appointed Ponte, Jose, Dr as Director
28 October 2024
Resigned Seo, Jinseok as Director
28 October 2024
Appointed Chae, Jeiwook as Director
28 October 2024
Appointed Jang, Seungdeok as Director
28 October 2024
Resigned Kwon, Bong Jin as Director
4 September 2024
Resigned Owen, Michael John as Director
5 January 2024
Resigned Jeong, Seung Wook as Director
5 January 2024
Appointed Kwon, Bong Jin as Director
1 February 2023
Appointed Owen, Michael John as Director
1 June 2021
Resigned Owen, Michael John, Dr as Director
1 June 2021
Appointed Seo, Jinseok as Director
1 June 2021
1 June 2021
Appointed Jeong, Seung Wook as Director
1 June 2021
Resigned Mackenzie Lamb, Alan Peter as Director
15 July 2020
28 May 2020
1 January 2018
1 July 2017
Appointed Owen, Michael John, Dr as Director
26 April 2016
18 April 2016
24 April 2015
25 April 2014
25 April 2014
Appointed Mackenzie Lamb, Alan Peter as Director
28 March 2014
28 February 2014
13 December 2010
27 September 2010
Resigned Watts, Andrew Graham as Director
18 May 2009
Resigned Solbe, Jennifer Mary as Director
28 November 2008
3 October 2008
4 September 2008
Appointed Solbe, Jennifer Mary as Director
4 September 2008
Appointed Watts, Andrew Graham as Director
4 September 2008
4 September 2008
4 September 2008
4 September 2008
Resigned Aderyn, Diane as Secretary
4 September 2008
21 November 2007
Appointed Aderyn, Diane as Secretary
21 November 2007
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 1
Companies where Iksuda Therapeutics Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (2)
1 June 2021
Ceased Ip2ipo Limited — Owns 25–50% of shares
1 June 2021
Ceased North East Technology (GP) Limited — Has significant influence or control
Filings 149
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 7 September 2026 | Resolutions | |||
| 27 August 2026 | Statement of capital following an allotment of shares | |||
| 21 August 2026 | Memorandum and Articles of Association | |||
| 31 May 2026 | Full accounts | 31 December 2025 | ||
| 13 November 2025 | Confirmation statement with updates | 2 November 2025 |
Some other companies at this address
Other companies in this industry
Liverpool
Caerphilly
Oxford
Sandwich
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →